title: Retrospective validation of genomic biomarkers-- what are the questions, challenges and strategies for developing useful relationships to clinical outcomes-- workshop summary.
authors.affiliation: Office of Biostatistics, Office of Pharmacoepidemiology and Statistical Science, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD 20993, USA. wangs@cder.fda.gov
authors.forename: S-J
authors.initials: SJ
authors.lastname: Wang
authors.forename: N
authors.initials: N
authors.lastname: Cohen
authors.forename: D A
authors.initials: DA
authors.lastname: Katz
authors.forename: G
authors.initials: G
authors.lastname: Ruano
authors.forename: P M
authors.initials: PM
authors.lastname: Shaw
authors.forename: B
authors.initials: B
authors.lastname: Spear
mesh_terms: D002986:Clinical Trials as Topic; D015195:Drug Design; D004345:Drug Industry; D023381:Endpoint Determination; D005819:Genetic Markers; D023281:Genomics; D010597:Pharmacogenetics / Q000379:methods*; D012189:Retrospective Studies; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D005819:Genetic Markers